Carregant...
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story
ABSTRACT: The anti-malarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ) have been suggested as promising agents against the new coronavirus SARS-CoV-2 that induces COVID-19 and as a possible therapy for shortening the duration of the viral disease. The antiviral effects of CQ and HCQ have be...
Guardat en:
| Publicat a: | Appl Microbiol Biotechnol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7847229/ https://ncbi.nlm.nih.gov/pubmed/33515285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00253-021-11094-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|